About
George Dunbar joined Arboretum Ventures in 2010 as a Venture Partner. George utilizes his extensive healthcare operating experience as the former CEO of a number of venture-backed healthcare companies to evaluate new investment opportunities in diagnostics, life science tools, and medical devices. George currently serves as the Executive Chairman of the Board of Directors at CerviLenz and serves on the boards of directors for KFx Medical and IntelliCyt Corporation. Prior to joining Arboretum, George was the President, CEO, and Chairman of Aastrom Biosciences [NASDAQ: ASTM], a clinical development stage healthcare company based in Ann Arbor, Michigan. Prior to Aastrom, George worked with several national venture capital firms, serving as the CEO of early-stage life sciences companies, including Quantum Dot (acquired by Invitrogen) and Epic Therapeutics (acquired by Baxter Healthcare).
Position in the VCSift Database
- • 8 investors at Arboretum Ventures are tracked.
- • 5 investors hold the Venture Partner role in VCSift. George Dunbar is one of them.
- • 182 investors are based in Detroit, Michigan, United States.
Data sourced from 410,343 investor profiles. Updated June 2026.
Investment Focus
- Location
- Detroit, US
Contact Information
Find more investors like George
Search Investors